Top compounds associated with response to MECP2


Feature Type Standardized
Nominal ANOVA
mRNA selumetinib:PLX-4032 (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.07 0.05
mRNA lapatinib gCSI pan-cancer AAC -0.11 0.05
mRNA KIN001-266 GDSC1000 pan-cancer AAC 0.066 0.05
mRNA WZ-1-84 GDSC1000 pan-cancer AAC 0.099 0.05
mRNA vorinostat:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.069 0.05
mRNA navitoclax:MST-312 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.07 0.05
mRNA PD-0325901 CCLE pan-cancer AAC -0.082 0.05
mRNA BRD-K99006945 CTRPv2 pan-cancer AAC -0.1 0.06
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.06 0.06
mRNA selumetinib:JQ-1 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.066 0.06
Download CSV